Augmented reality during robot-assisted prostate removal
Part of Cancer, Kidney & urinary clinical trials.
This study tests whether using augmented reality (a computer overlay) during robot-assisted surgery for prostate cancer can help the surgeon remove the cancer more precisely. It may be an option for people with low or intermediate risk prostate cancer who have good erectile function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have prostate cancer confirmed by biopsy and have not had any treatment for it yet.
- Your cancer is considered low or intermediate risk (PSA 20 or less, tumor stage T2b or less, and Gleason grade group 3 or less).
- You have good erectile function (score of 20 or higher on the IIEF-5 questionnaire).
- You are able to have a special MRI (multiparametric MRI) without any medical reasons that would prevent it.
- You are at least 18 years old.
- You agree to take part in the trial and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding a 3D augmented-reality model to standard robot-assisted prostate surgery can help doctors remove the cancer while better preserving sexual function. It is for men whose MRI shows the cancer may have slightly spread outside the prostate.
This trial is testing whether robot-assisted surgery can be a safe and effective way to treat early-stage prostate or kidney cancer. If you are eligible, it could give you access to a less invasive surgical option.
This study looks at a robotic prostate operation that aims to remove only the affected side while keeping the urethra (the tube for urination) to help preserve urinary function. It’s for people with low- to intermediate-risk, one-sided prostate cancer and no spread to lymph nodes, bones, or other organs.
This trial uses special imaging to guide surgery for rectal cancer. It studies whether detailed scans taken before surgery can help doctors remove the cancer more precisely.
This trial tests whether using a combined PSMA-PET/MRI and ultrasound navigation system during robot-assisted prostate removal can help the surgeon remove the cancer more completely while preserving surrounding tissue. It is for patients with early-stage prostate cancer that is just starting to spread outside the prostate.
This trial tests a robot-assisted method for taking prostate biopsies using a new type of ultrasound probe. It may help men with certain high-risk features get a more precise diagnosis.
Hear when a new Prostatic Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.